Cytek Biosciences annual gross profit
2020
2021
2022
2023
2024
2025
Cytek Biosciences Gross Profit Growth & History (CTKB)
Cytek Biosciences's gross profit was $104.5M for fiscal 2025.
View full Cytek Biosciences company overviewCytek Biosciences annual gross profit history
| Fiscal year | Period ended | Gross profit | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | $104.5M | −$6.6M | −5.98% |
| 2024 | 2024-12-31 | $111.1M | $1.7M | +1.54% |
| 2023 | 2023-12-31 | $109.4M | $8.5M | +8.37% |
| 2022 | 2022-12-31 | $101.0M | $21.8M | +27.58% |
| 2021 | 2021-12-31 | $79.1M | $27.4M | +53.05% |
| 2020 | 2020-12-31 | $51.7M | — | — |
Cytek Biosciences quarterly gross profit
Q2.20
Q3.20
Q1.21
Q2.21
Q3.21
Q4.21
Q1.22
Q2.22
Q3.22
Q4.22
Q1.23
Q2.23
Q3.23
Q4.23
Q1.24
Q2.24
Q3.24
Q4.24
Q1.25
Q2.25
Q3.25
Q4.25
Q1.26
Q2.26
| Fiscal quarter | Period ended | Gross profit | Change | YoY change |
|---|---|---|---|---|
| Q2 2026 | 2026-06-30 | $28.3M | $4.5M | +18.74% |
| Q1 2026 | 2026-03-31 | $21.3M | $1.1M | +5.44% |
| Q4 2025 | 2025-12-31 | $32.9M | −$767,000 | −2.28% |
| Q3 2025 | 2025-09-30 | $27.6M | −$1.5M | −5.01% |
| Q2 2025 | 2025-06-30 | $23.9M | −$1.6M | −6.17% |
| Q1 2025 | 2025-03-31 | $20.2M | −$2.9M | −12.41% |
| Q4 2024 | 2024-12-31 | $33.7M | $604,000 | +1.83% |
| Q3 2024 | 2024-09-30 | $29.0M | $1.8M | +6.72% |
| Q2 2024 | 2024-06-30 | $25.4M | −$2.7M | −9.68% |
| Q1 2024 | 2024-03-31 | $23.0M | $2.0M | +9.39% |
| Q4 2023 | 2023-12-31 | $33.0M | $3.7M | +12.51% |
| Q3 2023 | 2023-09-30 | $27.2M | $316,000 | +1.18% |
| Q2 2023 | 2023-06-30 | $28.2M | $3.6M | +14.66% |
| Q1 2023 | 2023-03-31 | $21.0M | $861,000 | +4.27% |
| Q4 2022 | 2022-12-31 | $29.4M | $5.7M | +24.28% |
| Q3 2022 | 2022-09-30 | $26.9M | $5.6M | +26.25% |
| Q2 2022 | 2022-06-30 | $24.6M | $4.8M | +24.39% |
| Q1 2022 | 2022-03-31 | $20.2M | $5.7M | +39.29% |
| Q4 2021 | 2021-12-31 | $23.6M | — | — |
| Q3 2021 | 2021-09-30 | $21.3M | $5.7M | +36.25% |
| Q2 2021 | 2021-06-30 | $19.7M | $11.5M | +138.75% |
| Q1 2021 | 2021-03-31 | $14.5M | — | — |
| Q3 2020 | 2020-09-30 | $15.6M | — | — |
| Q2 2020 | 2020-06-30 | $8.3M | — | — |
Cytek Biosciences gross profit trends
Over the last five fiscal years, Cytek Biosciences's gross profit increased from $51.7M to $104.5M, a change of $52.8M. The latest reported quarter, Q2 2026, shows $28.3M.
About the metric
What gross profit means
Gross profit is the amount of revenue remaining after the direct costs of producing and delivering a company’s goods or services. It helps show the dollars available to cover operating expenses before operating income, interest, and taxes.
Calculation and source
SEC-reported and calculated gross profit
TickerStat uses gross profit reported in company SEC filings when available. Otherwise, it calculates gross profit as SEC-reported revenue minus aligned cost of revenue for the same fiscal period. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Cytek Biosciences source filings ↗